Concepts (180)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endoscopy | 13 | 2022 | 332 | 3.740 |
Why?
|
| Skull Base | 11 | 2022 | 47 | 3.550 |
Why?
|
| Rhinitis | 6 | 2023 | 175 | 3.110 |
Why?
|
| Rhinitis, Allergic | 3 | 2023 | 43 | 2.090 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 3 | 2017 | 16 | 1.710 |
Why?
|
| Sinusitis | 4 | 2021 | 210 | 1.710 |
Why?
|
| Neurosurgical Procedures | 4 | 2021 | 212 | 1.700 |
Why?
|
| Frontal Sinus | 2 | 2022 | 7 | 1.490 |
Why?
|
| Otolaryngology | 2 | 2022 | 53 | 1.450 |
Why?
|
| Nasal Septum | 3 | 2018 | 28 | 1.370 |
Why?
|
| Paranasal Sinuses | 4 | 2018 | 60 | 1.330 |
Why?
|
| Cerebrospinal Fluid Leak | 2 | 2017 | 10 | 1.210 |
Why?
|
| Turbinates | 3 | 2022 | 11 | 1.190 |
Why?
|
| Sella Turcica | 2 | 2017 | 17 | 1.190 |
Why?
|
| Skull Base Neoplasms | 2 | 2016 | 11 | 1.100 |
Why?
|
| Postoperative Complications | 8 | 2022 | 2204 | 1.040 |
Why?
|
| Olfaction Disorders | 2 | 2022 | 62 | 0.970 |
Why?
|
| Angiofibroma | 1 | 2023 | 4 | 0.900 |
Why?
|
| Eustachian Tube | 1 | 2023 | 9 | 0.900 |
Why?
|
| Patient Satisfaction | 3 | 2022 | 454 | 0.890 |
Why?
|
| Ear Diseases | 1 | 2023 | 19 | 0.890 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 2023 | 47 | 0.870 |
Why?
|
| Olfactory Cortex | 1 | 2022 | 5 | 0.860 |
Why?
|
| Encephalocele | 1 | 2022 | 24 | 0.830 |
Why?
|
| Nasal Surgical Procedures | 3 | 2018 | 8 | 0.820 |
Why?
|
| Ambulatory Care Facilities | 1 | 2022 | 103 | 0.800 |
Why?
|
| Hypersensitivity | 1 | 2023 | 154 | 0.800 |
Why?
|
| Embolization, Therapeutic | 1 | 2023 | 238 | 0.730 |
Why?
|
| Nasal Cavity | 2 | 2018 | 91 | 0.720 |
Why?
|
| Rhinoplasty | 3 | 2018 | 34 | 0.720 |
Why?
|
| Surgery, Computer-Assisted | 2 | 2017 | 97 | 0.680 |
Why?
|
| Telemedicine | 1 | 2021 | 168 | 0.660 |
Why?
|
| Nasal Lavage | 1 | 2018 | 2 | 0.660 |
Why?
|
| Humans | 39 | 2023 | 86656 | 0.650 |
Why?
|
| Surgical Flaps | 2 | 2019 | 241 | 0.630 |
Why?
|
| Diet | 1 | 2021 | 443 | 0.630 |
Why?
|
| Sublingual Immunotherapy | 1 | 2017 | 2 | 0.630 |
Why?
|
| Withholding Treatment | 1 | 2018 | 112 | 0.620 |
Why?
|
| Nutrition Surveys | 4 | 2023 | 114 | 0.610 |
Why?
|
| Desensitization, Immunologic | 1 | 2017 | 36 | 0.610 |
Why?
|
| Invasive Pulmonary Aspergillosis | 1 | 2017 | 8 | 0.600 |
Why?
|
| Pituitary Neoplasms | 1 | 2017 | 62 | 0.600 |
Why?
|
| Transanal Endoscopic Surgery | 1 | 2017 | 2 | 0.590 |
Why?
|
| Sleep Wake Disorders | 1 | 2018 | 115 | 0.590 |
Why?
|
| Orbit | 1 | 2017 | 37 | 0.580 |
Why?
|
| Patient Safety | 2 | 2016 | 211 | 0.580 |
Why?
|
| Cricoid Cartilage | 1 | 2016 | 4 | 0.580 |
Why?
|
| Neurosurgery | 1 | 2017 | 84 | 0.570 |
Why?
|
| Laryngoplasty | 1 | 2016 | 5 | 0.570 |
Why?
|
| Allergens | 1 | 2017 | 179 | 0.570 |
Why?
|
| Esthesioneuroblastoma, Olfactory | 1 | 2016 | 2 | 0.560 |
Why?
|
| Cross-Sectional Studies | 5 | 2023 | 1618 | 0.550 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 2016 | 24 | 0.540 |
Why?
|
| Adenoma | 1 | 2017 | 237 | 0.530 |
Why?
|
| Quality Improvement | 3 | 2018 | 427 | 0.530 |
Why?
|
| Tracheotomy | 1 | 2015 | 18 | 0.520 |
Why?
|
| Otologic Surgical Procedures | 1 | 2015 | 13 | 0.520 |
Why?
|
| Trachea | 1 | 2016 | 293 | 0.520 |
Why?
|
| Depression | 1 | 2019 | 472 | 0.520 |
Why?
|
| Laryngostenosis | 1 | 2015 | 16 | 0.520 |
Why?
|
| Tracheal Stenosis | 1 | 2015 | 23 | 0.510 |
Why?
|
| Intraoperative Complications | 1 | 2016 | 185 | 0.510 |
Why?
|
| Nose | 5 | 2022 | 94 | 0.510 |
Why?
|
| Nasal Obstruction | 3 | 2018 | 21 | 0.460 |
Why?
|
| Young Adult | 7 | 2023 | 5977 | 0.430 |
Why?
|
| Facial Asymmetry | 1 | 2012 | 12 | 0.420 |
Why?
|
| Facial Expression | 1 | 2012 | 51 | 0.410 |
Why?
|
| Body Image | 1 | 2012 | 76 | 0.410 |
Why?
|
| Child, Preschool | 5 | 2021 | 3612 | 0.410 |
Why?
|
| Retrospective Studies | 10 | 2021 | 8476 | 0.410 |
Why?
|
| Child | 6 | 2023 | 6933 | 0.400 |
Why?
|
| Adolescent | 7 | 2023 | 8988 | 0.390 |
Why?
|
| Male | 17 | 2020 | 40995 | 0.380 |
Why?
|
| Reoperation | 3 | 2018 | 593 | 0.380 |
Why?
|
| United States | 5 | 2023 | 6674 | 0.370 |
Why?
|
| Adult | 10 | 2023 | 25648 | 0.360 |
Why?
|
| Patient Readmission | 3 | 2018 | 329 | 0.350 |
Why?
|
| Asthma | 1 | 2017 | 955 | 0.350 |
Why?
|
| Postoperative Period | 2 | 2022 | 302 | 0.340 |
Why?
|
| Female | 15 | 2020 | 44566 | 0.330 |
Why?
|
| Aged | 8 | 2020 | 18407 | 0.320 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2022 | 3366 | 0.310 |
Why?
|
| Middle Aged | 9 | 2019 | 25027 | 0.290 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2021 | 2585 | 0.280 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2018 | 237 | 0.260 |
Why?
|
| Databases, Factual | 3 | 2018 | 816 | 0.250 |
Why?
|
| Anti-Bacterial Agents | 2 | 2021 | 747 | 0.250 |
Why?
|
| Smell | 2 | 2022 | 109 | 0.240 |
Why?
|
| Treatment Outcome | 5 | 2021 | 7982 | 0.230 |
Why?
|
| Aged, 80 and over | 3 | 2019 | 6511 | 0.230 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2023 | 1313 | 0.230 |
Why?
|
| Gray Matter | 1 | 2022 | 33 | 0.210 |
Why?
|
| Olfactory Bulb | 1 | 2022 | 40 | 0.210 |
Why?
|
| Facial Pain | 1 | 2021 | 10 | 0.210 |
Why?
|
| Adenoidectomy | 1 | 2021 | 23 | 0.200 |
Why?
|
| Cadaver | 2 | 2020 | 184 | 0.200 |
Why?
|
| Office Visits | 1 | 2021 | 44 | 0.200 |
Why?
|
| Bayes Theorem | 1 | 2023 | 361 | 0.200 |
Why?
|
| Infant, Newborn | 2 | 2017 | 2380 | 0.190 |
Why?
|
| Neuroimaging | 1 | 2021 | 113 | 0.190 |
Why?
|
| Chronic Disease | 2 | 2021 | 972 | 0.190 |
Why?
|
| Infant | 2 | 2017 | 3048 | 0.180 |
Why?
|
| Frailty | 1 | 2020 | 58 | 0.170 |
Why?
|
| Cognitive Dysfunction | 1 | 2021 | 133 | 0.170 |
Why?
|
| Drug-Eluting Stents | 1 | 2018 | 16 | 0.170 |
Why?
|
| Prognosis | 2 | 2017 | 3681 | 0.170 |
Why?
|
| Absorbable Implants | 1 | 2018 | 34 | 0.170 |
Why?
|
| Immunoglobulin E | 1 | 2019 | 144 | 0.160 |
Why?
|
| Fluorescein | 1 | 2018 | 16 | 0.160 |
Why?
|
| Odontoid Process | 1 | 2018 | 3 | 0.160 |
Why?
|
| Nasopharynx | 1 | 2018 | 47 | 0.160 |
Why?
|
| Prevalence | 2 | 2020 | 1240 | 0.160 |
Why?
|
| Autografts | 1 | 2017 | 28 | 0.150 |
Why?
|
| Administration, Cutaneous | 1 | 2017 | 58 | 0.150 |
Why?
|
| Elective Surgical Procedures | 1 | 2018 | 117 | 0.150 |
Why?
|
| Operating Rooms | 1 | 2018 | 126 | 0.150 |
Why?
|
| Mucous Membrane | 1 | 2017 | 83 | 0.150 |
Why?
|
| North America | 1 | 2017 | 180 | 0.150 |
Why?
|
| Health Surveys | 1 | 2018 | 239 | 0.150 |
Why?
|
| Follow-Up Studies | 2 | 2016 | 3639 | 0.150 |
Why?
|
| Surveys and Questionnaires | 2 | 2017 | 2502 | 0.150 |
Why?
|
| Odds Ratio | 1 | 2019 | 679 | 0.150 |
Why?
|
| Safety | 1 | 2017 | 152 | 0.150 |
Why?
|
| Allografts | 1 | 2017 | 172 | 0.140 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2017 | 57 | 0.140 |
Why?
|
| Skin Transplantation | 1 | 2017 | 172 | 0.140 |
Why?
|
| Transplants | 1 | 2016 | 40 | 0.140 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2018 | 238 | 0.140 |
Why?
|
| Immunocompromised Host | 1 | 2017 | 140 | 0.140 |
Why?
|
| Cystic Fibrosis | 1 | 2017 | 112 | 0.140 |
Why?
|
| Academic Medical Centers | 1 | 2018 | 378 | 0.140 |
Why?
|
| Perioperative Care | 1 | 2017 | 162 | 0.140 |
Why?
|
| Treatment Failure | 1 | 2016 | 286 | 0.140 |
Why?
|
| Infant, Premature, Diseases | 1 | 2016 | 78 | 0.130 |
Why?
|
| Hemorrhage | 1 | 2017 | 267 | 0.130 |
Why?
|
| Mastoid | 1 | 2015 | 17 | 0.130 |
Why?
|
| Cochlear Implantation | 1 | 2015 | 31 | 0.130 |
Why?
|
| Acute Disease | 1 | 2017 | 827 | 0.130 |
Why?
|
| Laryngoscopy | 1 | 2015 | 44 | 0.130 |
Why?
|
| Societies, Medical | 1 | 2017 | 573 | 0.120 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2017 | 864 | 0.110 |
Why?
|
| Survival Analysis | 1 | 2017 | 1540 | 0.110 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2017 | 581 | 0.110 |
Why?
|
| Beauty | 1 | 2012 | 8 | 0.110 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2015 | 219 | 0.110 |
Why?
|
| Photography | 1 | 2012 | 37 | 0.100 |
Why?
|
| Intensive Care Units | 1 | 2015 | 374 | 0.100 |
Why?
|
| Risk Factors | 3 | 2018 | 5416 | 0.100 |
Why?
|
| Hemangioblasts | 1 | 2010 | 1 | 0.090 |
Why?
|
| Pluripotent Stem Cells | 1 | 2010 | 31 | 0.090 |
Why?
|
| Hepatitis C, Chronic | 1 | 2009 | 126 | 0.080 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2010 | 292 | 0.080 |
Why?
|
| Biopsy | 1 | 2009 | 1163 | 0.070 |
Why?
|
| Kidney Diseases | 1 | 2009 | 416 | 0.070 |
Why?
|
| Cell Differentiation | 1 | 2010 | 1471 | 0.060 |
Why?
|
| Taste Disorders | 1 | 2020 | 7 | 0.050 |
Why?
|
| HIV Infections | 1 | 2009 | 773 | 0.050 |
Why?
|
| Logistic Models | 2 | 2018 | 1185 | 0.050 |
Why?
|
| Sphenoid Sinus | 1 | 2020 | 6 | 0.050 |
Why?
|
| Evidence-Based Practice | 1 | 2019 | 45 | 0.040 |
Why?
|
| Dementia | 1 | 2021 | 187 | 0.040 |
Why?
|
| Cervical Vertebrae | 1 | 2018 | 79 | 0.040 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2018 | 261 | 0.040 |
Why?
|
| Respiratory Function Tests | 1 | 2017 | 136 | 0.040 |
Why?
|
| Multivariate Analysis | 1 | 2018 | 999 | 0.030 |
Why?
|
| Sex Factors | 1 | 2018 | 1053 | 0.030 |
Why?
|
| Polysomnography | 1 | 2015 | 151 | 0.030 |
Why?
|
| Age Factors | 1 | 2018 | 1849 | 0.030 |
Why?
|
| Genotype | 1 | 2017 | 1853 | 0.030 |
Why?
|
| Brain | 1 | 2021 | 2220 | 0.020 |
Why?
|
| Hematuria | 1 | 2009 | 48 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2010 | 188 | 0.020 |
Why?
|
| Hematoma | 1 | 2009 | 104 | 0.020 |
Why?
|
| Quality of Life | 1 | 2015 | 1587 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2009 | 692 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2009 | 1809 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2009 | 1672 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2010 | 878 | 0.010 |
Why?
|
| Models, Biological | 1 | 2010 | 1752 | 0.010 |
Why?
|
| Animals | 1 | 2010 | 26706 | 0.010 |
Why?
|